Estrogen receptor beta as target for colorectal cancer prevention

Keyphrases

• Colorectal Cancer 100%
• Colorectal Cancer Prevention 100%
• Estrogen Receptor β 100%
• Low Incidence 50%
• Estrogen 50%
• Colon 50%
• Epidemiologic Studies 50%
• United States 50%
• Colon Adenocarcinoma 50%
• Polyps 50%
• Colorectal Polyps 50%
• Early Diagnosis 50%
• Patients at Risk 50%
• Clinical Experience 50%
• Colorectal Carcinoma 50%
• Protective Response 50%
• Leading Causes of Death 50%
• Rodent Models 50%
• Natural Compounds 50%
• Phytoestrogens 50%
• Clinical Approach 50%
• Dietary Approaches 50%
• Colorectal Adenomatous Polyps 50%
• Selective Agonist 50%
• Promote Apoptosis 50%
• Estrogen Signaling 50%
• Tumor Stage 50%
• Preventive Approach 50%
• Chemopreventive 50%
• Slow Evolution 50%
• ESR2 50%

Medicine and Dentistry

• Colorectal Cancer Prevention 100%
• Colorectal Carcinoma 100%
• Estrogen Receptor Beta 100%
• Neoplasm 33%
• Cohort Effect 33%
• Programmed Cell Death 33%
• Colon 33%
• Polyp 33%
• Colorectal Polyp 33%
• Early Diagnosis 33%
• Tubular Adenoma 33%
• Phytoestrogen 33%
• Medical Decision Making 33%
• Natural Product 33%
• Colon Adenocarcinoma 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Colorectal Carcinoma 100%
• Estrogen Receptor Beta 100%
• Neoplasm 20%
• Preclinical Study 20%
• Epidemiology 20%
• Polyp 20%
• Colorectal Polyp 20%
• Adenomatous Polyp 20%
• Phytoestrogen 20%
• Natural Product 20%
• Colon Adenocarcinoma 20%